US5271927A
(en)
*
|
1986-02-13 |
1993-12-21 |
Celltech Limited |
Antibody conjugates with macrocyclic ligands
|
US4877868A
(en)
*
|
1986-03-12 |
1989-10-31 |
Neorx Corporation |
Radionuclide antibody coupling
|
EP0284071B1
(de)
*
|
1987-03-26 |
1994-06-08 |
Neorx Corporation |
Metall-Radionuklid-markierte Proteine und Glykoproteine zur Diagnose und Therapie
|
US5091514A
(en)
*
|
1987-03-26 |
1992-02-25 |
Neorx Corporation |
Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
|
US4965392A
(en)
*
|
1987-03-26 |
1990-10-23 |
Neorx Corporation |
Chelating compounds for metal-radionuclide labeled proteins
|
DE3710730A1
(de)
*
|
1987-03-31 |
1988-10-20 |
Schering Ag |
Substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
|
US5177192A
(en)
*
|
1987-04-02 |
1993-01-05 |
Centocor, Incorporated |
Method for labeling antibodies with a metal ion
|
JPH02504387A
(ja)
*
|
1987-04-02 |
1990-12-13 |
セントカー・カーデイオバスキユラー・イメージング・パートナーズ・エルピー |
金属イオンで抗体を標識付けする方法
|
US5053493A
(en)
*
|
1987-04-02 |
1991-10-01 |
Centocor Cardiovascular Imaging Partners, L.P. |
Method for labeling antibodies with a metal ion
|
EP0300431A3
(de)
*
|
1987-07-22 |
1990-06-27 |
Neorx Corporation |
Methode zur Bindung von radionukliden Anschwefel enthaltende Chelate
|
US5021556A
(en)
*
|
1987-07-22 |
1991-06-04 |
Neorx Corporation |
Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
|
IL87405A0
(en)
*
|
1987-08-12 |
1989-01-31 |
Immunomedics Inc |
Radiolabeled agents and methods and kits for the production thereof
|
GB8719042D0
(en)
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
GB8719041D0
(en)
*
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
US4933470A
(en)
*
|
1987-10-05 |
1990-06-12 |
Neorx Corporation |
Method of synthesis of vicinal diamines
|
US5648471A
(en)
*
|
1987-12-03 |
1997-07-15 |
Centocor, Inc. |
One vial method for labeling antibodies with Technetium-99m
|
DE68923274T2
(de)
*
|
1988-02-09 |
1995-11-09 |
Mallinckrodt Inc |
Verfahren zur herstellung eines mit metall-radionuklid-markierten proteins.
|
US5202451A
(en)
*
|
1988-02-17 |
1993-04-13 |
Neorx Corporation |
Anchimeric radiometal chelating compounds
|
US5075099A
(en)
*
|
1988-05-31 |
1991-12-24 |
Neorx Corporation |
Metal radionuclide chelating compounds for improved chelation kinetics
|
US4988496A
(en)
*
|
1988-05-31 |
1991-01-29 |
Neorx Corporation |
Metal radionuclide chelating compounds for improved chelation kinetics
|
US5202109A
(en)
*
|
1988-06-10 |
1993-04-13 |
Neorx Corporation |
Conjugates for bone imaging and bone cancer therapy
|
US5089249A
(en)
*
|
1988-06-10 |
1992-02-18 |
Neorx Corporation |
Conjugates for bone imaging and bone cancer therapy
|
US5218128A
(en)
*
|
1988-06-15 |
1993-06-08 |
Centocor, Inc. |
Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
|
US4839467A
(en)
*
|
1988-06-15 |
1989-06-13 |
University Of Cincinnati |
Radioactive rhenium complexed to 2-hydroxy isobutyric acid
|
US5180816A
(en)
*
|
1988-08-24 |
1993-01-19 |
Centocor |
One vial method for labeling protein/linker conjugates with technetium-99M
|
US5066789A
(en)
*
|
1988-09-30 |
1991-11-19 |
Neorx Corporation |
Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
|
EP0434765B1
(de)
*
|
1988-09-30 |
1995-11-08 |
Neorx Corporation |
Wässrige additivsysteme, verfahren und polymerteilchen
|
US4925650A
(en)
*
|
1988-11-16 |
1990-05-15 |
Mallinckrodt, Inc. |
Technetium -99m complex for examining the renal function
|
DE69024826T2
(de)
*
|
1989-02-10 |
1996-06-27 |
Celltech Therapeutics Ltd |
Aza-Macrozyklen und Verfahren zu deren Herstellung
|
US5342936A
(en)
*
|
1989-02-10 |
1994-08-30 |
David Parker |
Tetra-aza macrocycles and processes for their preparation
|
US5053503A
(en)
*
|
1989-02-17 |
1991-10-01 |
Centocor |
Chelating agents
|
US5206370A
(en)
*
|
1989-02-24 |
1993-04-27 |
Johnson Matthey, Inc. |
Certain pyridyl hydrazines and hydrazides useful for protein labeling
|
US5162240A
(en)
*
|
1989-06-16 |
1992-11-10 |
Hitachi, Ltd. |
Method and apparatus of fabricating electric circuit pattern on thick and thin film hybrid multilayer wiring substrate
|
US5247077A
(en)
*
|
1989-06-23 |
1993-09-21 |
Celltech Limited |
Tri-aza macrocycles and processes for their preparation
|
US5443816A
(en)
*
|
1990-08-08 |
1995-08-22 |
Rhomed Incorporated |
Peptide-metal ion pharmaceutical preparation and method
|
DE3930674A1
(de)
*
|
1989-09-11 |
1991-03-21 |
Diagnostikforschung Inst |
Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
|
US5162505A
(en)
*
|
1989-09-19 |
1992-11-10 |
Centocor |
Proteins modified with positively charged carriers and compositions prepared therefrom
|
US5112953A
(en)
*
|
1989-12-29 |
1992-05-12 |
Neorx Corporation |
Radiolabeled proteins for diagnostic or therapeutic use
|
US5185433A
(en)
*
|
1990-04-09 |
1993-02-09 |
Centocor, Inc. |
Cross-linking protein compositions having two or more identical binding sites
|
US5684135A
(en)
*
|
1990-04-18 |
1997-11-04 |
Celltech Therapeutics Limited |
Conjugate compounds containing aza-macro-cycles and processes for their preparation
|
DE69124132T2
(de)
*
|
1990-04-18 |
1997-06-05 |
Celltech Therapeutics Ltd |
Tetra-aza-makrozyklen, Verfahren zu ihrer Herstellung und ihre Anwendung in NMR-Bildformung
|
US5080883A
(en)
*
|
1990-05-11 |
1992-01-14 |
Mallinckrodt, Inc. |
99 mtcn3s-conjugated anti-bibrin monoclonal antibody as an in vivo diagnostic agent for imaging
|
US5382654A
(en)
*
|
1992-02-05 |
1995-01-17 |
Mallinckrodt Medical, Inc. |
Radiolabelled peptide compounds
|
WO1992005802A1
(en)
*
|
1990-09-28 |
1992-04-16 |
Neorx Corporation |
Polymeric carriers for release of covalently linked agents
|
US5645815A
(en)
*
|
1991-02-08 |
1997-07-08 |
Diatide, Inc. |
Radiolabled compounds for thrombus imaging
|
US5849261A
(en)
*
|
1991-02-08 |
1998-12-15 |
Diatide, Inc. |
Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
|
US5443815A
(en)
*
|
1991-11-27 |
1995-08-22 |
Diatech, Inc. |
Technetium-99m labeled peptides for imaging
|
US5561220A
(en)
*
|
1991-02-08 |
1996-10-01 |
Diatech, Inc. |
Technetium-99m labeled peptides for imaging inflammation
|
US5736122A
(en)
*
|
1991-02-08 |
1998-04-07 |
Diatide, Inc. |
Technetium-99m labeled peptides for thrombus imaging
|
US6107459A
(en)
*
|
1991-02-08 |
2000-08-22 |
Diatide, Inc. |
Technetium-99m labeled peptides for diagnostic imaging
|
US5997844A
(en)
*
|
1991-02-08 |
1999-12-07 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging
|
US6019958A
(en)
*
|
1991-02-08 |
2000-02-01 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging inflammation
|
EP0570493B1
(de)
*
|
1991-02-08 |
2000-01-05 |
Diatide, Inc. |
Technetium-99m markierte Polypeptide zur Bildformung
|
US5965107A
(en)
*
|
1992-03-13 |
1999-10-12 |
Diatide, Inc. |
Technetium-99m labeled peptides for imaging
|
GB9113487D0
(en)
*
|
1991-06-21 |
1991-08-07 |
Amersham Int Plc |
Agents for hypoxic cells
|
US5225180A
(en)
*
|
1991-09-10 |
1993-07-06 |
Diatech, Inc. |
Technetium-99m labeled somatostatin-derived peptides for imaging
|
US5783170A
(en)
*
|
1991-11-27 |
1998-07-21 |
Diatide, Inc. |
Peptide-metal chelate conjugates
|
US5643549A
(en)
*
|
1992-02-20 |
1997-07-01 |
Rhomed Incorporated |
Leukostimulatory agent for in vivo leukocyte tagging
|
US5326856A
(en)
*
|
1992-04-09 |
1994-07-05 |
Cytogen Corporation |
Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
|
US5508020A
(en)
*
|
1992-06-05 |
1996-04-16 |
Diatech, Inc. |
Technetium-99M labeled peptides for imaging
|
US5968476A
(en)
*
|
1992-05-21 |
1999-10-19 |
Diatide, Inc. |
Technetium-99m labeled peptides for thrombus imaging
|
DE4301871A1
(de)
*
|
1993-01-13 |
1994-07-14 |
Diagnostikforschung Inst |
Neue Mittel zur Diagnose von Gefäßerkrankungen
|
US5879657A
(en)
*
|
1993-03-30 |
1999-03-09 |
The Dupont Merck Pharmaceutical Company |
Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
|
DE4311022C2
(de)
*
|
1993-03-31 |
1996-07-11 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner vom Typ S¶3¶N¶2¶ für radioaktive Isotope und deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
AU6493894A
(en)
*
|
1993-03-31 |
1994-10-24 |
Mallinckrodt Medical, Inc. |
Radiopharmaceutical formulations having non-stannous reductants
|
DE4310999C2
(de)
*
|
1993-03-31 |
1996-07-18 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner vom Typ XN¶1¶S¶1¶X' für radioaktive Isotope und deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
DE4311023C2
(de)
*
|
1993-03-31 |
1996-05-02 |
Diagnostikforschung Inst |
Bifunktionelle chalkogenatom-unterbrochene Chelatbildner von Typ XN¶1¶S¶1¶O¶1¶ für radioaktive Isotope, deren Metallkomplexe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Mittel
|
AU6834194A
(en)
*
|
1993-05-14 |
1994-12-12 |
Mallinckrodt Medical, Inc. |
Ligand precursors for incorporation into peptides
|
US5449761A
(en)
*
|
1993-09-28 |
1995-09-12 |
Cytogen Corporation |
Metal-binding targeted polypeptide constructs
|
JPH10504534A
(ja)
*
|
1994-06-16 |
1998-05-06 |
ネオルクス コーポレイション |
放射性標識アネキシン−ガラクトース結合体
|
US5942210A
(en)
*
|
1994-11-15 |
1999-08-24 |
Cytogen Corporation |
Methods for lyoprotecting a macromolecule using tricine
|
DE19505960A1
(de)
*
|
1995-02-21 |
1996-08-22 |
Deutsches Krebsforsch |
Konjugat zur individuellen Dosierung von Arzneimitteln
|
ATE483733T1
(de)
|
1995-06-14 |
2010-10-15 |
Univ California |
Hochaffine humane antikörper gegen tumorantigene
|
DE19536780A1
(de)
*
|
1995-09-21 |
1997-03-27 |
Diagnostikforschung Inst |
Bifunktionelle sulfidhaltige Sulfonamid-Chelatbildner vom Typ XSNY für radioaktive Isotope
|
EP0869820B1
(de)
*
|
1995-12-28 |
2005-03-09 |
The General Hospital Corporation |
Verbindungen, verfahren und kits zur bildgebung des kardiovaskulären systems und von thromben
|
US6187286B1
(en)
*
|
1996-12-27 |
2001-02-13 |
The General Hospital Corporation |
Tumor imaging agents, methods and kits
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
US20050059031A1
(en)
|
2000-10-06 |
2005-03-17 |
Quantum Dot Corporation |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
|
EP1327145B1
(de)
|
2000-10-06 |
2009-03-11 |
Life Technologies Corporation |
Zellen mit spektraler signatur sowie verfahren zu ihrer herstellung und nutzung
|
AU2002230524A1
(en)
|
2000-11-16 |
2002-05-27 |
California Institute Of Technology |
Apparatus and methods for conducting assays and high throughput screening
|
US6972324B2
(en)
|
2001-05-18 |
2005-12-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Antibodies specific for CD44v6
|
US6955888B2
(en)
|
2001-06-11 |
2005-10-18 |
Xenoport |
Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
|
JP4355210B2
(ja)
|
2001-11-30 |
2009-10-28 |
フルイディグム コーポレイション |
微小流体デバイスおよび微小流体デバイスの使用方法
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
NZ538284A
(en)
|
2002-07-18 |
2008-04-30 |
Helix Biopharma Corp |
Use of urease and targeting molecule for inhibiting cancer cell growth
|
US20050043233A1
(en)
|
2003-04-29 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
|
GB0416062D0
(en)
*
|
2004-07-19 |
2004-08-18 |
Amersham Plc |
Improved N4 chelator conjugates
|
NZ548255A
(en)
|
2004-02-02 |
2010-10-29 |
Ambrx Inc |
Modified human interferon polypeptides and their uses
|
EP1771205B1
(de)
|
2004-06-18 |
2016-10-26 |
Ambrx, Inc. |
Neuartige antigen-bindende polypeptide und ihre verwendungen
|
US7385028B2
(en)
|
2004-12-22 |
2008-06-10 |
Ambrx, Inc |
Derivatization of non-natural amino acids and polypeptides
|
CA2594557C
(en)
|
2004-12-22 |
2016-04-26 |
Ambrx, Inc. |
Modified human growth hormone
|
CN101454461A
(zh)
|
2005-11-16 |
2009-06-10 |
Ambrx公司 |
包括非天然氨基酸的方法和组合物
|
MX2009002523A
(es)
|
2006-09-08 |
2009-03-20 |
Ambrx Inc |
Polipeptido de plasma humano modificado o andamios fc y sus usos.
|
CA2680227C
(en)
|
2007-03-07 |
2021-01-26 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of autoimmune conditions
|
MX2009010531A
(es)
|
2007-03-30 |
2009-11-26 |
Ambrx Inc |
Polipeptidos de fgf-21 modificados y usos de los mismos.
|
CA2699394C
(en)
|
2007-09-17 |
2020-03-24 |
The Regents Of The University Of California |
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
|
MX2010003099A
(es)
|
2007-09-21 |
2010-05-17 |
Univ California |
Interferon de objetivo demuestra actividades potentes apoptoticas y antitumorales.
|
WO2009067636A2
(en)
|
2007-11-20 |
2009-05-28 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
NZ586947A
(en)
|
2008-02-08 |
2012-11-30 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
EP2318029B1
(de)
|
2008-07-23 |
2017-11-01 |
Ambrx, Inc. |
Modifizierte bovine g-csf-polypeptide und ihre verwendung
|
ES2631915T3
(es)
|
2008-09-26 |
2017-09-06 |
Ambrx, Inc. |
Polipéptidos modificados de eritropoyetina animal y sus usos
|
CA2738033C
(en)
|
2008-09-26 |
2019-11-26 |
Ambrx, Inc. |
Non-natural amino acid replication-dependent microorganisms and vaccines
|
CA2751612A1
(en)
|
2009-02-06 |
2010-08-12 |
The Regents Of The University Of California |
Calcium-binding agents induce hair growth and/or nail growth
|
EA201290541A1
(ru)
|
2009-12-21 |
2013-05-30 |
Амбркс, Инк. |
Модифицированные бычьи соматотропиновые полипептиды и их применение
|
AU2010341518B2
(en)
|
2009-12-21 |
2014-01-09 |
Ambrx, Inc. |
Modified porcine somatotropin polypeptides and their uses
|
CA2797033C
(en)
|
2010-04-22 |
2021-10-19 |
Longevity Biotech, Inc. |
Highly active polypeptides and methods of making and using the same
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
HRP20240267T1
(hr)
|
2010-08-17 |
2024-05-10 |
Ambrx, Inc. |
Modificirani relaksin polipeptidi i njihove uporabe
|
US11246915B2
(en)
|
2010-09-15 |
2022-02-15 |
Applied Molecular Transport Inc. |
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
|
KR101881176B1
(ko)
|
2010-09-15 |
2018-07-23 |
랜달 제이 미스니 |
박테리아 독소에서 유래된 수송 서열을 이용한 생물활성제 시스템 및 방법
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
DK2621523T3
(da)
|
2010-09-29 |
2017-11-20 |
Uti Lp |
Fremgangsmåder til fremstilling af autoimmune sygdomme ved anvendelse af biokompatible bioabsorberbare nanokugler
|
US9511151B2
(en)
|
2010-11-12 |
2016-12-06 |
Uti Limited Partnership |
Compositions and methods for the prevention and treatment of cancer
|
WO2012125582A1
(en)
|
2011-03-11 |
2012-09-20 |
Board Of Regents Of The University Of Nebraska |
Biomarker for coronary artery disease
|
DK2694095T3
(en)
|
2011-04-05 |
2018-05-28 |
Longevity Biotech Inc |
COMPOSITIONS COMPREHENSIVE GLUCAGON ANALOGS AND METHODS FOR PREPARING AND USING THE SAME
|
US20150080559A1
(en)
|
2011-05-27 |
2015-03-19 |
Ambrx, Inc. |
Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin Derivatives
|
CN103717595A
(zh)
|
2011-05-27 |
2014-04-09 |
Ambrx公司 |
含有非天然氨基酸连接的海兔毒素衍生物的组合物、涉及该海兔毒素衍生物的方法及其用途
|
PE20142331A1
(es)
*
|
2012-02-03 |
2015-01-17 |
Lg Life Sciences Ltd |
Metodo para preparar un compuesto mediante la reaccion de adicion de michael novedosa usando agua o varios acidos como aditivo
|
US10988516B2
(en)
|
2012-03-26 |
2021-04-27 |
Uti Limited Partnership |
Methods and compositions for treating inflammation
|
EP2858676B1
(de)
|
2012-06-07 |
2019-03-13 |
Ambrx, Inc. |
Antikörper-wirkstoff-konjugate für prostataspezifisches membranantigen
|
SG11201408347UA
(en)
|
2012-06-14 |
2015-01-29 |
Ambrx Inc |
Anti-psma antibodies conjugated to nuclear receptor ligand polypeptides
|
EP3488870B1
(de)
|
2012-06-19 |
2024-03-20 |
Ambrx, Inc. |
Anti-cd70-antikörper-arzneimittelkonjugate
|
US9603948B2
(en)
|
2012-10-11 |
2017-03-28 |
Uti Limited Partnership |
Methods and compositions for treating multiple sclerosis and related disorders
|
US9789164B2
(en)
|
2013-03-15 |
2017-10-17 |
Longevity Biotech, Inc. |
Peptides comprising non-natural amino acids and methods of making and using the same
|
US11559580B1
(en)
|
2013-09-17 |
2023-01-24 |
Blaze Bioscience, Inc. |
Tissue-homing peptide conjugates and methods of use thereof
|
US10519247B2
(en)
|
2013-11-01 |
2019-12-31 |
Board Of Regents,The University Of Texas System |
Targeting HER2 and HER3 with bispecific antibodies in cancerous cells
|
RU2696876C2
(ru)
|
2013-11-04 |
2019-08-07 |
Ютиай Лимитед Партнершип |
Способы и композиции для устойчивой иммунотерапии
|
RU2723178C2
(ru)
|
2014-05-07 |
2020-06-09 |
ЭППЛАЙД МОЛЕКЬЮЛАР ТРАНСПОРТ ЭлЭлСи |
Слитые молекулы, происходящие от Cholix-токсина, для пероральной доставки биологически активных нагрузок
|
WO2016065326A2
(en)
|
2014-10-24 |
2016-04-28 |
Bristol-Myers Squibb Company |
Modified fgf-21 polypeptides and uses thereof
|
SG10201913957PA
(en)
|
2015-05-06 |
2020-03-30 |
Uti Lp |
Nanoparticle compositions for sustained therapy
|
US10193422B2
(en)
|
2015-05-13 |
2019-01-29 |
Makita Corporation |
Power tool
|
BR112018009004A8
(pt)
|
2015-11-03 |
2019-02-26 |
Ambrx Inc |
conjugados anti-cd3-folato e seus usos
|
ES2975747T3
(es)
|
2015-11-30 |
2024-07-12 |
Univ California |
Administración de carga útil específica de tumor y activación inmunitaria utilizando un anticuerpo humano que se dirige a un antígeno de superficie celular de tumor altamente específico
|
CA3020601A1
(en)
|
2016-04-12 |
2017-10-19 |
Blaze Bioscience, Inc. |
Methods of treatment using chlorotoxin conjugates
|
WO2017181149A1
(en)
|
2016-04-15 |
2017-10-19 |
Blaze Bioscience, Inc. |
Methods of treating breast cancer
|
EP3538551A4
(de)
|
2016-11-10 |
2020-11-11 |
Fortis Therapeutics, Inc. |
Cd46-specifische effektorzellen und verwendungen davon
|
CA3043277A1
(en)
|
2016-11-11 |
2018-05-17 |
The Regents Of The University Of California |
Anti-cd46 antibodies and methods of use
|
CN110291205A
(zh)
|
2016-12-12 |
2019-09-27 |
塞弗德公司 |
自动反应盒中的整合的免疫pcr和核酸分析
|
WO2018129200A2
(en)
|
2017-01-05 |
2018-07-12 |
The Regents Of The University Of California |
Pac1 receptor agonists (maxcaps) and uses thereof
|
KR102670432B1
(ko)
|
2017-02-08 |
2024-05-28 |
브리스톨-마이어스 스큅 컴퍼니 |
약동학적 인핸서를 포함하는 변형된 렐락신 폴리펩티드 및 그의 용도
|
EP4082558B1
(de)
|
2018-03-08 |
2023-08-23 |
Applied Molecular Transport Inc. |
Von toxinen abgeleitete konstrukte zur oralen verabreichung
|
WO2019191728A1
(en)
|
2018-03-29 |
2019-10-03 |
Ambrx, Inc. |
Humanized anti-prostate-specific membrane antigen (psma) antibody drug conjugates
|
WO2020047176A1
(en)
|
2018-08-28 |
2020-03-05 |
Ambrx, Inc. |
Anti-cd3 antibody folate bioconjugates and their uses
|
HUE065882T2
(hu)
|
2018-09-11 |
2024-06-28 |
Ambrx Inc |
Interleukin-2-polipeptid-konjugátumok és alkalmazásaik
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス,インコーポレイテッド |
インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
|
EP4083058A3
(de)
|
2018-11-07 |
2023-01-11 |
Applied Molecular Transport Inc. |
Verabreichungskonstrukte für die transzytose und zugehörige verfahren
|
WO2020168017A1
(en)
|
2019-02-12 |
2020-08-20 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
TW202120521A
(zh)
|
2019-08-16 |
2021-06-01 |
美商應用分子運輸公司 |
組合物、配方及介白素生產及純化
|
WO2021173889A1
(en)
|
2020-02-26 |
2021-09-02 |
Ambrx, Inc. |
Uses of anti-cd3 antibody folate bioconjugates
|
CN115243726A
(zh)
|
2020-03-11 |
2022-10-25 |
北京泰德制药股份有限公司 |
白介素-2多肽偶联物及其使用方法
|
WO2022032020A1
(en)
|
2020-08-07 |
2022-02-10 |
Fortis Therapeutics, Inc. |
Immunoconjugates targeting cd46 and methods of use thereof
|
KR20230073200A
(ko)
|
2020-08-20 |
2023-05-25 |
암브룩스, 인코포레이티드 |
항체-tlr 작용제 접합체, 그 방법 및 용도
|
MX2023011480A
(es)
|
2021-04-03 |
2023-12-06 |
Ambrx Inc |
Conjugados anticuerpo anti-her2-fármaco y usos de estos.
|
WO2024077277A1
(en)
|
2022-10-07 |
2024-04-11 |
Ambrx, Inc. |
Drug linkers and antibody conjugates thereof
|
WO2024155627A1
(en)
|
2023-01-16 |
2024-07-25 |
Ambrx, Inc. |
Anti-cd70 antibody-drug conjugates
|
WO2024178310A1
(en)
|
2023-02-23 |
2024-08-29 |
Ambrx, Inc. |
Trop2-directed antibody-drug conjugates and uses thereof
|